Education
About Us
Working with TipRanks
Follow Us
Kaken Pharmaceutical Co (JP:4521)
:4521
Earnings Data
Report Date
Feb 11, 2026TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
24.79Last Year’s EPS
129.08Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
JP:4521 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
JP:4521 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | ¥3680.00 | ¥3665.00 | -0.41% |
Aug 07, 2025 | ¥3920.09 | ¥3878.14 | -1.07% |
May 12, 2025 | ¥3911.31 | ¥3771.83 | -3.57% |
Feb 06, 2025 | ¥4104.50 | ¥4166.86 | +1.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Kaken Pharmaceutical Co (JP:4521) report earnings?
Kaken Pharmaceutical Co (JP:4521) is schdueled to report earning on Feb 11, 2026, TBA (Confirmed).
What is Kaken Pharmaceutical Co (JP:4521) earnings time?
Kaken Pharmaceutical Co (JP:4521) earnings time is at Feb 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Kaken Pharmaceutical Co stock?
The P/E ratio of Kaken Pharmaceutical Co is N/A.
What is JP:4521 EPS forecast?
JP:4521 EPS forecast for the fiscal quarter 2025 (Q3) is 24.79.